Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Galectin Inhibitor GR-MD-02

Known as: GR-MD-02, Galactoarabino-rhamnogalacturonate 
A carbohydrate-based galectin inhibitor, with potential antineoplastic activity. Galectin inhibitor GR-MD-02 binds to the carbohydrate-binding domain… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background Given the worldwide prevalence of NAFLD and NASH, there is a need to develop treatments to slow or reverse disease… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2018
2018
Pabrik Anhidrida Maleat dirancang dengan kapasitas produksi 70.000 ton/tahun, bahan baku untuk pembuatan Anhidrida Maleat adalah… Expand
Is this relevant?
Review
2017
Review
2017
A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis… Expand
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without approved… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Galectin-3 protein is critical to the development of liver fibrosis because galectin-3 null mice have attenuated fibrosis after… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without effective therapy. Some data… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?